FDA Approves Second OTC Naloxone for Opioid Overdose Management
FDA Issues Draft Guidance on Devices for Opioid Use Disorder
Zuranolone Effectively and Safely Treats Postpartum Depression
Only 3.3% of NIH-Funded Pediatric Clinical Trials Data Is Reusable
Pfizer Plant Damage May Cause Pharmaceutical Supply Chain Shortages
Comparing Merck and Pfizer’s 2022 ESG Ratings
Newly Approved Monoclonal Antibody Prevents RSV in Babies and Toddlers
Melanoma Drugs Repurposed Can Shrink Rare Brain Tumors
Majority of Patients Quit Weight-Loss Drugs Like Wegovy Within First Year
FDA Approves Over-the-Counter, Nonprescription Birth Control
White House National Response Plan Addresses Xylazine, Fentanyl Risk
Cipla Albuterol Sulfate Inhalation Aerosol Voluntarily Recalled
45% of Drinking Water Samples in the United States Contain PFAS
Biogen and Eisai Secure Traditional FDA Approval for Lequembi
Older and Immunocompromised Adults Advised to Get RSV Vaccine